Table 4.
Peptide | Length |
---|---|
BepiPred analysis (linear B-cell epitope) | |
GIPD | 4 |
| |
IEDB analysis (antigenic sites) | |
DHPLRLLRIG | 10 |
QAFLQEFVLPPVQLPQYFTFDLTAL | 35 |
KLITQPLPAA | |
| |
Surface accessible epitope | |
VQLPQYF | 7 |
Peptide | Length |
---|---|
BepiPred analysis (linear B-cell epitope) | |
GIPD | 4 |
| |
IEDB analysis (antigenic sites) | |
DHPLRLLRIG | 10 |
QAFLQEFVLPPVQLPQYFTFDLTAL | 35 |
KLITQPLPAA | |
| |
Surface accessible epitope | |
VQLPQYF | 7 |